Plus, oil sands, oily studies, and more, in today's links.
- Canadian oil is closer to home, and also provides a closer look at the environmental havoc wreaked by the process of extracting oil from oil sands.
- It's not a new suggestion that the drug company studies that make it into medical journals do not tell the whole story. But a new study takes a look at how data submitted to the FDA stacks up against what gets published.
- We are about 21 nanometers closer to self-powered electric devices. That amount sounds like a little step, but it could mean a lot.
- If this is the information age, Florence Nightingale was far ahead of her time. She helped bring about the use of applied statistics, as well as graphics for displaying quantitative information.
- For when those little mini-bottles of liquor on the plane don't work, an experimental drug may help travelers overcome jetlag.
Researchers don't publish all of their problems -- well I'm shocked. Come on - the information IS available. Also, the FDA regs require proof of safety and 'efficacy' ( effectiveness as near as I can tell). Your doctor should be able to figure it out.
And I don't work for a pharmaceutical. I did work for a large company that sold off its drug branch because it was too tough for them to make a profit -- despite some excellent products.
Bringing new drugs to market is a difficult and expensive proposal -- and as mentioned, all kinds of disclosure is required. On the other hand generics only need to prove that they're 'SUBSTANTIALLY' equivalent to the original drug. Maybe we should worry more about them.